Drug Screening Using IMD in Bladder Cancer
Drug Screening Using IMD in Bladder Cancer
Enrolling by invitation · NCT06204614 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Drug Screening Using IMD in Bladder Cancer | Muscle Invasive Bladder Urothelial Carcinoma | Enrolling by invitation | Early phase 1 | 2026-05-18 | NCT06204614 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brigham and Women's Hospital | 378 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |